Baxter International IncBAX
Price$23.64Intrinsic value$36.9256% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $11.5B+7.8% YoYTTM through 30 Jun 2026
Net Income -$1.1BTTM through 30 Jun 2026
Free Cash Flow $806MTTM through 30 Jun 2026

Margins

Current
Gross Margin33.0%
EBITDA Margin5.9%
Operating Margin2.4%
Net Margin-9.3%

Returns

-17.1%ROE
-5.4%ROA

Balance Sheet Health

Debt / Equity1.57x
Current Ratio1.85x
Net Debt$7.4B
Cash & Equivalents$2.2B

Quality Metrics

Altman Z-Score2.26
Piotroski F-Score5 / 9
FCF Margin7.0%
Rule of 408.3
Earnings-Beat Rate50.0%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $11.2B
Diluted EPS-$2.08TTM
'19'20'21'22'23'24'25
FY2025: $-1.87

Dividend

$0.02Per share, FY20260.08%Yield-55.0%5-yr growth

Capital Allocation

R&D Spend$512M
Capex Intensity4.5%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.